FN Clarivate Analytics Web of Science
VR 1.0
PT J
DE PLA-PEG-PLA; Polyethylenimine; Gene delivery; Cytotoxicity; DNA release
ID IN-VITRO CHARACTERIZATION; SUPPORTED LIPID-BILAYERS; BIODEGRADABLE
   NANOPARTICLES; DRUG-DELIVERY; ORAL DELIVERY; PARTICLE-SIZE; GOLD
   NANOPARTICLES; PLGA NANOPARTICLES; CELLULAR UPTAKE; HOLE FORMATION
ER

PT J
DE IFN-lambda 1; PLGA; Non-viral gene delivery; Therapy
ID ACID) NANOPARTICLES; INTERFERON; MICROSPHERES; DELIVERY;
   POLY(DL-LACTIDE-CO-GLYCOLIDE); MICROPARTICLES; VECTORS; THERAPY
ER

PT J
DE Cisplatin; Silver; Nanoparticles; Curcumin; Resistance
ID DRUG-RESISTANCE
ER

PT J
DE Fragile histidine triad; HT1080; Doxorubicin; Combination therapy; MTT
   assay; Flowcytometry
ID CYCLE ARREST; TUMOR-SUPPRESSOR; DNA-DAMAGE; FHIT; P53; PROTEIN;
   ANTAGONISTS; INHIBITION; EXPRESSION; APOPTOSIS
ER

PT J
DE Human astrocytes; Oligodendrocyte progenitors; Trichostatin A; Cell fate
   conversion; Myelin repair; Multiple sclerosis
ID HISTONE DEACETYLASE; SOMATIC-CELLS; THERAPEUTIC STRATEGY;
   FUNCTIONAL-NEURONS; GLIAL-CELLS; IN-VITRO; FIBROBLASTS; MOUSE;
   INHIBITION; APOPTOSIS
ER

PT J
DE Anticoagulant; Actinobacterial metabolites; Vascular calcification;
   Warfarin
ID VASCULAR CALCIFICATION; P-GLYCOPROTEIN; IN-VITRO; DRUGS; ANTIPLATELET;
   PHARMACOLOGY; MECHANISMS; EDOXABAN; WARFARIN; THERAPY
ER

PT J
DE DHR; SCAR; STS/TEN; DRESS; AGEP; HLA
ID STEVENS-JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; GENERALIZED
   EXANTHEMATOUS PUSTULOSIS; HUMAN-LEUKOCYTE ANTIGEN; INTRAVENOUS
   IMMUNOGLOBULIN; SYSTEMIC SYMPTOMS; DRESS SYNDROME; CARBAMAZEPINE;
   HLA-B-ASTERISK-15/02; HLA-A-ASTERISK-31/01
ER

PT J
DE Toxin/antitoxin; Modules; type II TA module; Rnl AB system;
   Gammaproteobacteria; Phylogenetic tree; Phage therapy; Antimicrobial
   photodynamic therapy
ID ESCHERICHIA-COLI TOXIN; PSEUDOMONAS-AERUGINOSA; RNASE LS; PROTEINS;
   VIRULENCE; INSIGHTS; BIOFILM; GENE; CLASSIFICATION; MECHANISM
ER

PT J
DE nerve regeneration; central nervous system; gene therapy;
   neurodegenerative disease; viral vector; adeno-associated virus;
   Alzheimer's disease; Parkinson's disease; Huntington's disease;
   amyotrophic lateral sclerosis; spinal muscular atrophy; neural
   regeneration
ID MUSCULAR-ATROPHY PHENOTYPE; MOUSE MODEL; ALZHEIMERS-DISEASE;
   CANAVAN-DISEASE; VIRAL VECTORS; DOUBLE-BLIND; AAV VECTORS; SPINAL-CORD;
   DELIVERY; BRAIN
ER

PT J
DE cerebral organoids; human brain; stem cells; neurons; astrocytes;
   neurodevelopmental disorders; neuropsychiatric disorders; autism
ID PLURIPOTENT STEM-CELLS; RECEPTOR EXPRESSION; HUMAN ES; IN-VITRO; MODEL;
   INHIBITION; CORTEX
ER

PT J
ER

PT J
ER

PT J
DE nerve regeneration; ischemic stroke; rehabilitation; constraint-induced
   movement therapy; nerve growth factors; functional recovery; neuronal
   plasticity; real time-polymerase chain reaction; western blot assay;
   rats; neural regeneration
ID USE-DEPENDENT EXAGGERATION; CEREBRAL-ARTERY OCCLUSION; NERVE
   GROWTH-FACTOR; NOGO-A; MOTOR FUNCTION; CORTICOSPINAL TRACT; SENSORIMOTOR
   CORTEX; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; CHRONIC STROKE
ER

PT J
DE Cadmium; Immunoprotection; Grass carp; Ctenopharyngodon idellus;
   Metallothionein; Vitamin E; Detoxification
ID CYPRINUS-CARPIO; CELL-DEATH; TOXICITY; FISH; CD; METALS; ROLES; CU
ER

PT J
DE Ambient fine particulate matter (PM2.5); Pulmonary structure and
   function; Mitochondrial dysfunction; Energy metabolic disorder
ID MITOCHONDRIAL TRANSCRIPTION FACTOR; AIR-POLLUTION; OXIDATIVE STRESS;
   RECEPTOR-GAMMA; UP-REGULATION; MORTALITY; RESPIRATION; PGC-1-ALPHA;
   EXPRESSION; HEALTH
ER

PT J
DE nano-complex; targeted delivery; fluorescence; gene therapy; antitumor
ID FOLATE RECEPTOR-ALPHA; ENHANCED PERMEABILITY; DRUG-DELIVERY; HUMAN
   CANCER; P53; NANOPARTICLES; ACID; THERAPY; SIRNA; NANOCARRIER
ER

PT J
DE Cubital tunnel; cubital tunnel syndrome; dry needling; entrapment;
   intramuscular stimulation; intramuscular therapy; neuropathy;
   neurodynamics; neural mobilization; physical therapy; ulnar nerve
ID MYOFASCIAL TRIGGER SPOTS; GENE-RELATED PEPTIDE; ULNAR NERVE;
   CONSERVATIVE TREATMENT; MANAGEMENT; PAIN; ACUPUNCTURE; ENTRAPMENT;
   ELBOW; STIMULATION
ER

PT J
DE Dry needling; intramuscular stimulation; intramuscular therapy; radial
   nerve; radial tunnel syndrome; posterior interosseous nerve; peripheral
   nerve entrapment; chronic pain
ID MYOFASCIAL TRIGGER SPOTS; GENE-RELATED PEPTIDE; LATERAL EPICONDYLITIS;
   NERVE ENTRAPMENT; PAIN; ACUPUNCTURE; ELBOW; NEUROPATHIES; RELIABILITY;
   MANAGEMENT
ER

PT J
DE anti-hepatitis C virus DAA; genetic variation; hepatitis C virus;
   interleukin
ID IL28B GENE; SPONTANEOUS CLEARANCE; PLUS SOFOSBUVIR; VIROLOGICAL
   RESPONSE; HCV INFECTION; ASSOCIATION; RIBAVIRIN; RS12979860; RESISTANCE;
   VARIANTS
ER

PT J
DE Anticancer activity; BRM270 nanoparticles; Human hepatoma cancer cells;
   Mechanical-milling method; Phyto-composite
ID AG-NPS; PROLIFERATION; RESISTANCE; MIGRATION; INVASION; EXTRACT; BREAST;
   MCF-7; A549
ER

PT J
DE cancer; genome editing; immunotherapy
ID CHIMERIC-ANTIGEN-RECEPTOR; HUMAN-PAPILLOMAVIRUS E6; NUCLEIC-ACID
   DETECTION; HL-A ANTIGENS; T-CELLS; GUIDE-RNA; CHROMOSOMAL
   REARRANGEMENTS; GENE KNOCKOUT; CAS9; CAR
ER

PT J
DE gene-environment interactions; individual differences; personalized
   psychiatry; zebrafish
ID DANIO-RERIO; DNA METHYLATION; BEHAVIORAL SYNDROMES; GENDER-DIFFERENCES;
   ANIMAL-MODELS; INHIBITORY AVOIDANCE; OOCYTE APOPTOSIS; ADULT ZEBRAFISH;
   RISK-TAKING; STRESS-AXIS
ER

PT J
DE Electric field; Keratinocytes; Cytochrome P450; Wound healing;
   Anti-aging
ID UP-REGULATION; EXPRESSION; STIMULATION; INFLAMMATION; METABOLISM;
   ACTIVATION; INHIBITORS; MIGRATION; THERAPY; CYP1A1
ER

PT J
DE glioblastoma; temozolomide; drug resistance; thioridazine; autophagy
ID NEWLY-DIAGNOSED GLIOBLASTOMA; CONNECTIVITY MAP; ADJUVANT TEMOZOLOMIDE;
   CELLULAR-DISTRIBUTION; TUMOR-GROWTH; RESISTANCE; TRIAL; ANGIOGENESIS;
   RADIATION; SURVIVAL
ER

PT J
DE epigenetics; leukemia; non coding RNA
ID ACUTE MYELOID-LEUKEMIA; MICRORNA EXPRESSION; GENE-EXPRESSION; CPG
   ISLAND; PROMOTER METHYLATION; MOLECULAR-GENETICS; DNA METHYLATION;
   DOWN-REGULATION; POOR-PROGNOSIS; CELL-LINES
ER

PT J
DE gene therapy; hepatocellular carcinoma; RNA interference; small
   interfering RNA
ID DOWN-REGULATION; TUMOR-GROWTH; SORAFENIB RESISTANCE; TARGETED DELIVERY;
   EARLY RECURRENCE; HEPATOMA-CELLS; SIRNA DELIVERY; CYCLIN-E; EXPRESSION;
   CANCER
ER

PT J
DE breast cancer; breast cancer stem cells (BCSC); cancer stem cells
   (CSCs); metastasis; microRNAs (miRNAs)
ID ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR GENES; REGULATES
   PROLIFERATION; MESENCHYMAL TRANSITION; COLORECTAL-CANCER;
   DOWN-REGULATION; MIR-200 FAMILY; SELF-RENEWAL; IN-VITRO; METASTASIS
ER

PT J
DE diagnosis; management; melanoma; therapy
ID CUTANEOUS MALIGNANT-MELANOMA; TUMOR-SUPPRESSOR GENES; ADOPTIVE CELL
   TRANSFER; METASTATIC MELANOMA; EPIGENETIC INACTIVATION; MOLECULAR
   CLASSIFICATION; CIRCULATING MICRORNAS; ABERRANT METHYLATION; DIAGNOSTIC
   BIOMARKER; IMPROVED SURVIVAL
ER

PT J
DE cancer; forkhead box proteins; viruses
ID HEPATITIS-B-VIRUS; FORKHEAD TRANSCRIPTION FACTORS; PROMOTES
   TUMOR-METASTASIS; INDICATES POOR-PROGNOSIS; DOWN-REGULATION;
   UP-REGULATION; HEPATOCELLULAR-CARCINOMA; T-CELLS; LATENT
   MEMBRANE-PROTEIN-1; EMERGING ROLES
ER

PT J
DE diabetes mellitus; endocrine-like cells; epigenetics; HDAC inhibitors;
   TMP269; TSA; WJMSCs
ID INSULIN GENE-TRANSCRIPTION; BONE-MARROW; STROMAL CELLS; DEACETYLASES;
   CHROMATIN; METHYLATION; GENERATION; INDUCTION; FAMILY; MICE
ER

PT J
DE amyotrophic lateral sclerosis (ALS); epidermal growth factor receptor
   (EGFR); extracellular signal-regulated kinases 1 and 2 (ERK1; 2); matrix
   metallopeptidase-2 (MMP-2); pituitary adenylate cyclase-activating
   polypeptide (PACAP)
ID CU/ZN SUPEROXIDE-DISMUTASE; HYPOXIA-INDUCIBLE FACTORS; MEDIATED
   UP-REGULATION; VEGF EXPRESSION; GENE-EXPRESSION; LUNG-CANCER; PACAP;
   RECEPTORS; VIP; PEPTIDE
ER

PT J
DE AR-42; chronic myeloid leukemia; HDACs; HO-1; ROS
ID OXIDATIVE STRESS; INDUCE APOPTOSIS; GENE-EXPRESSION; STEM-CELLS;
   RESISTANCE; INHIBITOR; ABL; ACETYLATION; MODULATION; AUTOPHAGY
ER

PT J
DE Bacterial nanocellulose; Gene activated matrix; Gene delivery;
   Controlled release; Biocompatibility
ID DRUG-DELIVERY SYSTEM; IN-VITRO; CONTROLLED-RELEASE; CELLULOSE; DNA;
   BONE; VIVO; REGENERATION; HYDROGELS; THERAPY
ER

PT J
DE Probiotic; Antibiotic resistance; Experimental evolution; Whole-genome
   sequencing
ID LACTIC-ACID BACTERIA; ANTIBIOTIC-RESISTANCE; MULTIDRUG TRANSPORTERS;
   SUSCEPTIBILITY; ORIGIN; MFS
ER

PT J
DE cell-printing technology; biliary system; 3D liver-on-a-chip
ID CULTURE; MODELS; MIMICKING; PLATFORM; BARRIER; TISSUE; LINE; FLOW; TOOL
ER

PT J
DE hereditary sensory and autonomic neuropathy V; nerve growth factor;
   NGF(R100W) mutation; pain; tyrosine receptor kinase A; p75 neurotrophic
   factor receptor
ID CONGENITAL INSENSITIVITY; NEUROPATHIC PAIN; SENSORY NEURONS; ACTIVATION;
   RECEPTOR; KINASE; GENE; MUTATION
ER

PT J
DE nerve regeneration; Alzheimer's disease; beta-amyloid precursor protein;
   amyloid beta; APP mutations; liquid chromatography-tandem mass
   chromatography; cellular localization; long A beta; neural regeneration
ID A673T VARIANT; APP; GENETICS; CLEAVAGE; DUTCH; GENERATION
ER

PT J
DE nerve regeneration; facial paralysis; electroacupuncture; glial
   cell-derived neurotrophic factor; N-cadherin; crush injury; neuronal
   apoptosis; facial neuron; nerve demyelination; neural regeneration
ID RETINOIC ACID; SPINAL-CORD; MOUSE MODEL; N-CADHERIN; GDNF; RAT;
   ORGANIZATION; NUCLEUS; IDENTIFICATION; REPRESENTATION
ER

PT J
DE Ginsenoside Rh2; CNNM1; Angiogenesis; Prostate Cancer
ID TUMOR ANGIOGENESIS; RAPID DETECTION; THERAPY; CELLS; NANOPARTICLES;
   NANOMATERIALS; METASTASIS; EXTRACTION; VEGF
ER

PT J
DE Plasmid DNA; Poly(amidoamine) Dendrimers; Gold Nanoparticles; Folic
   Acid; Gene Expression
ID GENE DELIVERY; ETHIDIUM-BROMIDE; DRUG-DELIVERY; HEPG2 CELLS; PAMAM;
   APOPTOSIS; ASSAY; SIZE; EFFICIENCY; PRINCIPLES
ER

PT J
DE CRISPR delivery; polyethylenimine (PEI); CD-PEI
ID GENE DELIVERY; LUMINESCENT; EFFICIENT; NANODOTS
ER

PT J
DE Biofilm; Carbapenemase; Hospital effluent; Plasmids; Carbapenem
ID ANTIBIOTIC-RESISTANCE GENES; WASTE-WATER EFFLUENTS;
   AEROMONAS-HYDROPHILA; PSEUDOMONAS-AERUGINOSA; MULTIDRUG-RESISTANCE;
   BACTERIA; RESERVOIR; SEWAGE; ENTEROBACTERIACEAE; DEGRADATION
ER

PT J
DE Diclofenac; Activated sludge; Adsorption; Biotransformation;
   Cometabolism; Microbial community
ID WASTE-WATER TREATMENT; TRACE ORGANIC CONTAMINANTS; PHARMACEUTICAL
   COMPOUNDS; MIXED CULTURE; REMOVAL; FATE; BIODEGRADATION; TRANSFORMATION;
   ANTIBIOTICS; ELIMINATION
ER

PT J
DE Soil-plant system; Antibiotic resistant pathogenic bacteria; Antibiotic
   resistance genes; Phage therapy; Cocktail treatment; Polyvalent phage
ID ESCHERICHIA-COLI; SEWAGE-SLUDGE; GENES; ACCUMULATION; ABUNDANCE; CARROT;
   VEGETABLES; WASTE; QUANTIFICATION; QUALITY
ER

PT J
DE DNA methylation; DNA methyltransferases (DNMTs); DNA methyltransferase
   Inhibitors (DNMTi); NSC 106084; NSC 14778
ID DNA METHYLTRANSFERASE INHIBITORS; TUMOR-SUPPRESSOR GENES; SMALL-MOLECULE
   INHIBITORS; ACID-DERIVATIVES; EPIGENETIC THERAPY; CANCER EPIGENOME;
   SOLID TUMORS; METHYLATION; DESIGN; 5-AZACYTIDINE
ER

PT J
DE Biodistribution; Biohybrids; Metformin; Nanoparticle
ID ANTIDIABETIC ACTIVITY; IN-VIVO; MECHANISM; STREPTOZOTOCIN; COMBINATION;
   RESISTANCE; EXTRACT
ER

PT J
DE Schizophrenia; Enhancer; Brain regions; Biological; Pathway
ID COMMON VARIANTS; NEURONAL MIGRATION; ASSOCIATION; DISEASE; MATTER;
   CORTEX; RISK; GENE; PATHOGENESIS; DYSFUNCTION
ER

PT J
DE Adrenalectomy; Ventral tegmental area; Medial prefrontal cortex;
   Morphine withdrawal aversive memories
ID MESSENGER-RNA EXPRESSION; MEDIAL PREFRONTAL CORTEX; VENTRAL TEGMENTAL
   AREA; LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; OPIATE WITHDRAWAL;
   NEUROTROPHIC FACTOR; DOPAMINE NEURONS; SYNAPTIC PLASTICITY; NEGATIVE
   FEEDBACK
ER

PT J
DE Chrysanthemum indicum polysaccharide; Duck hepatitis A virus;
   Autophagosomes; PI3KC3
ID HEPATITIS-A VIRUS; REPLICATION; RNA; CELLS
ER

PT J
DE Schizophrenia; Bipolar disorder; Genetics; Cross-disorder; Gene; Pathway
ID GENOME-WIDE ASSOCIATION; PROTEIN-KINASE-II; MAJOR DEPRESSIVE DISORDER;
   PSYCHIATRIC-DISORDERS; GENOTYPE IMPUTATION; SEX-DIFFERENCES; ADDICTION;
   SYMPTOMS; IDENTIFICATION; POLYMORPHISMS
ER

PT J
DE Transcription; FOXP1; Splicing; CHD8; RBFOX1; Network; Autism
ID DE-NOVO MUTATIONS; INTELLECTUAL DISABILITY; TRANSCRIPTIONAL REGULATION;
   MOSAIC MUTATIONS; CHD8; FOXP1; RISK; EXPRESSION; MOUSE; SCHIZOPHRENIA
ER

PT J
DE Heroin dependence; Opioid related genes; OPRD1; Polymorphisms; Life
   stress
ID OPIOID RECEPTOR GENE; FAMILY-BASED ASSOCIATION; OPIATE ADDICTION; OPRM1;
   POLYMORPHISM; VARIANTS; METAANALYSIS; COCAINE; RISK; BEHAVIOR
ER

PT J
DE Sex differences; Somatization symptoms; Serotonin transporter; DNA
   methylation
ID SEROTONIN TRANSPORTER GENE; EARLY ADVERSITY; DEPRESSION; DISORDERS;
   PSYCHOPATHOLOGY; POLYMORPHISM; ASSOCIATION; 5-HTTLPR; RECEPTOR; STRESS
ER

PT J
DE Major depression; Cardiovascular diseases; Energy metabolism;
   Epigenomics; Proteomics
ID LONG NONCODING RNAS; ACUTE CORONARY SYNDROME; MITOCHONDRIAL
   RESPIRATORY-CHAIN; ANTERIOR CINGULATE CORTEX; INCREASED DNA METHYLATION;
   C677T GENE POLYMORPHISM; GENOME-WIDE ANALYSIS; FACTOR-I LEVELS; MAJOR
   DEPRESSION; BIPOLAR DISORDER
ER

PT J
DE ZNF804A; Cannabis; Psychosis; Schizotypy; Gene-environment interaction
ID BIPOLAR DISORDER; SCHIZOTYPAL PERSONALITY; FOLLOW-UP; SCHIZOPHRENIA;
   ASSOCIATION; METAANALYSIS; POPULATION; EXPRESSION; INSIGHTS; OUTCOMES
ER

PT J
DE Micronutrients; ADHD; Predictors; Vitamins; Minerals; Treatment;
   Children
ID ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY
   DISORDER; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL;
   OPEN-LABEL TRIAL; PSYCHOMETRIC PROPERTIES; DIETARY PATTERNS; OXIDATIVE
   STRESS; IRON-DEFICIENCY; ADULT OUTCOMES
ER

PT J
DE 5-HTTLPR; Bipolar disorder; Meta-analysis; Population-based and
   family-based association studies; Treatment response
ID FAMILY-BASED ASSOCIATION; FLUVOXAMINE ANTIDEPRESSANT ACTIVITY; MAJOR
   DEPRESSIVE DISORDER; GENOME-WIDE ASSOCIATION; PROTEIN GENE SLC6A4;
   FUNCTIONAL POLYMORPHISM; MOOD-DISORDERS; SUICIDAL-BEHAVIOR; CANDIDATE
   GENES; LINKAGE DISEQUILIBRIUM
ER

PT J
DE Autism; Enzymatic antioxidants; Oxidants; Immune cells; Cerebellum
ID GLUTATHIONE REDOX IMBALANCE; SPECTRUM DISORDERS; SUPEROXIDE-DISMUTASE;
   MOUSE MODELS; CHILDREN; BRAIN; METABOLISM; EXPRESSION; BIOMARKERS;
   MERCURY
ER

PT J
DE Glucocorticoid; Corticotropin releasing hormone; Dexamethasone;
   Cortisol; Memory; Trauma
ID POSTTRAUMATIC-STRESS-DISORDER; CORTICOTROPIN-RELEASING-FACTOR;
   HORMONE-RECEPTOR 1; ACUTE PSYCHOSOCIAL STRESS; MAJOR DEPRESSIVE
   DISORDER; MEDIAL PREFRONTAL CORTEX; CIVILIAN TRAUMA VICTIMS;
   FREE-CORTISOL-LEVELS; FKBP5 GENE VARIANTS; HEAT-SHOCK-PROTEIN
ER

PT J
DE E2F1; Depression; Electroconvulsive therapy; Gene expression; Peripheral
   blood
ID ENDOTHELIAL GROWTH-FACTOR; TRANSCRIPTION FACTOR; GENE-EXPRESSION;
   TUMOR-SUPPRESSOR; TELOMERE LENGTH; FAMILY-MEMBERS; APOPTOSIS; DISORDER;
   TARGET; PROLIFERATION
ER

PT J
DE Autism spectrum disorder; Functional connectivity; Structural
   connectivity; Insula; Oxytocin; Music therapy
ID IMPROVISATIONAL MUSIC-THERAPY; OXYTOCIN RECEPTOR GENE; RANDOMIZED
   CONTROLLED-TRIAL; LIKELIHOOD ESTIMATION METAANALYSIS; ENHANCED STANDARD
   CARE; MIRROR-NEURON SYSTEM; SPECTRUM DISORDER; INTRANASAL OXYTOCIN;
   PLASMA OXYTOCIN; NETWORK CONNECTIVITY
ER

PT J
DE Antibiotic resistance pathogenic bacteria; ARGs; Phage therapy; Biochar;
   Soil column
ID MOBILE GENETIC ELEMENTS; VETERINARY ANTIBIOTICS; BACTERIOPHAGES;
   GROUNDWATER; IRRIGATION; LEACHATES; AMENDMENT; CHINA
ER

PT J
DE Idiopathic pulmonary fibrosis; usual interstitial pneumonia;
   pathogenetic mechanisms
ID BLEOMYCIN HAMSTER MODEL; FORCED VITAL CAPACITY; ANTI-ACID TREATMENT;
   LUNG FIBROSIS; GASTROESOPHAGEAL-REFLUX; TRANSCRIPTIONAL LEVEL; DISEASE
   PROGRESSION; N-ACETYLCYSTEINE; GENE-EXPRESSION; OPEN-LABEL
ER

PT J
DE Canakinumab; interleukin 1 inhibitor; biologics; hyperimmunoglobulinemia
   D; mevalonate kinase deficiency
ID MEVALONATE KINASE-DEFICIENCY; FAMILIAL MEDITERRANEAN FEVER; HYPER-IGD
   SYNDROME; TERM-FOLLOW-UP; COLCHICINE-RESISTANT; SCHNITZLER SYNDROME;
   PERIODIC SYNDROME; DOUBLE-BLIND; EFFICACY; ANAKINRA
ER

PT J
DE Biomarkers; genomics; immunostimulory therapy; metabolomics;
   multi-omics; precision medicine; sepsis-induced immunoparalysis;
   transcriptomics
ID INTERFERON-GAMMA IMMUNOTHERAPY; COLONY-STIMULATING FACTOR; CYTOKINE
   PRODUCTION; INDUCED IMMUNOSUPPRESSION; GENE-EXPRESSION; DOUBLE-BLIND;
   GENOME-WIDE; CELL-DEATH; IN-VIVO; PD-1
ER

PT J
DE Toca FC; 5-fluorocytosine; combination therapy; cytosine deaminase;
   glioblastoma; recurrent high-grade glioma; retroviral replicating
   vector; Toca 511; Toca FC; vocimagene amiretrorepvec
ID RETROVIRAL REPLICATING VECTOR; GENE-THERAPY; GLIOBLASTOMA;
   5-FLUOROCYTOSINE; 5-FLUOROURACIL; TEMOZOLOMIDE; FLUCYTOSINE;
   BEVACIZUMAB; COMBINATION; LOMUSTINE
ER

PT J
DE Tumor gene therapy; IL-24 cytokine; melanoma differentiation-associated
   gene-7 (MDA-7); cell penetrating peptides (CPPs); tumor homing peptides
   (THPs)
ID DIFFERENTIATION-ASSOCIATED GENE-7; CELLS IN-VITRO; RENAL-CARCINOMA
   CELLS; NECROSIS-FACTOR-ALPHA; MELANOMA DIFFERENTIATION; TARGETED
   DELIVERY; ANTICANCER IMMUNITY; AMINOPEPTIDASE N; SUPPRESSOR GENE; HOMING
   PEPTIDES
ER

PT J
DE Acute ischemic stroke; gene therapy; growth factor; intra-arterial
   delivery; neurogenesis; neuroprotection; steam cells; vectors
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; MARROW
   MONONUCLEAR-CELLS; BLOOD-BRAIN-BARRIER; CEREBRAL-ARTERY OCCLUSION;
   ADENOVIRUS-MEDIATED GDNF; TRIPLE-GENE THERAPY; NEUROTROPHIC FACTOR;
   GLOBAL-ISCHEMIA; PLASMINOGEN-ACTIVATOR
ER

PT J
DE PTCL; comprehensive genomic profile; targeted therapy;
   genomically-informed treatment
ID OPEN-LABEL; PHASE-II; THERAPY; PATIENT; DISEASE
ER

PT J
DE Berardinelli-Seip congenital lipodystrophy; Familial partial
   lipodystrophy; Congenital generalized lipodystrophy; Consanguinity;
   Metreleptin
ID FAMILIAL PARTIAL LIPODYSTROPHY; CONGENITAL GENERALIZED LIPODYSTROPHY;
   LEPTIN-REPLACEMENT; INSULIN-RESISTANCE; DIABETES-MELLITUS;
   ADIPOSE-TISSUE; MUTATIONS; AGPAT2; HETEROGENEITY; PREVALENCE
ER

PT J
DE Caloric restriction; cholic acid; DNA damage response; inflammation;
   lipid metabolism
ER

PT J
DE Acetylation; Epigenetic factors; Genetic factors; Gut flora;
   Methylation; Schizophrenia
ID MONOZYGOTIC TWINS DISCORDANT; DNA-METHYLATION; BRAIN AXIS;
   ENVIRONMENTAL-FACTORS; HISTONE METHYLATION; FOLATE-DEFICIENCY;
   PREFRONTAL CORTEX; FAMILY HISTORY; MOUSE MODEL; MICROBIOTA
ER

PT J
DE Depression; Ultrasound radiation; Plasticity; Neuroinflammation;
   Glycogen synthase kinase 3 (GSK-3); Mice
ID GLYCOGEN-SYNTHASE KINASE-3; MICROGLIAL ACTIVATION; NEUROTROPHIC FACTORS;
   DEPRESSION RESEARCH; PREFRONTAL CORTEX; ANIMAL-MODELS; SOCIAL STRESS;
   BRAIN; MICE; NEUROGENESIS
ER

PT J
DE Schizophrenia; beta-secretase-1 (BACE1); Neuregulin-1 (NRG1); Clinical
   symptoms; Biomarker
ID PREFRONTAL CORTEX; ASSOCIATION; BACE1; EXPRESSION; PROTEIN; GENES;
   SUSCEPTIBILITY; POLYMORPHISMS; PSYCHOSIS; GENETICS
ER

PT J
DE Gene-by-environment interaction; Stress; Anxiety; PTSD; Depression;
   Epigenetic; Trauma
ID POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD TRAUMA; ENVIRONMENT
   INTERACTION; ADCYAP1R1 GENOTYPE; OBSTETRIC COMPLICATIONS; WIDE
   ASSOCIATION; BIPOLAR DISORDER; CANDIDATE GENES; COMPLEX TRAITS; PAC1
   RECEPTOR
ER

PT J
ID POSTTRAUMATIC-STRESS-DISORDER; GENOME-WIDE ASSOCIATION; RECEPTOR GENE
   NR3C1; TOLL-LIKE RECEPTORS; GLUCOCORTICOID-RECEPTOR; TRAUMA EXPOSURE;
   EPIGENETIC AGE; NEUROPEPTIDE FF; SKA2 METHYLATION; PERIPHERAL-BLOOD
ER

PT J
DE Childhood trauma; Glucocorticoid receptor; Fear conditioning; Plasticity
ID CORTICOSTERONE REGULATION; EPIGENETIC REGULATION; POSTTRAUMATIC-STRESS;
   CHILDHOOD TRAUMA; EXPRESSION; BRAIN; DEPRESSION; GENE; DISORDER;
   HIPPOCAMPUS
ER

PT J
ID ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; RENAL CYSTOGENESIS;
   PROSTATE-CANCER; MTOR PATHWAY; IN-VITRO; METABOLISM; 2-DEOXY-D-GLUCOSE;
   CELLS; GROWTH
ER

PT J
DE adipose tissue; HCV; hepatic; insulin resistance
ID NONDIABETIC PATIENTS; DIABETES-MELLITUS; GLYCEMIC CONTROL;
   LIVER-CIRRHOSIS; GENOTYPE 1; HCV; ABT-450/R-OMBITASVIR; MECHANISMS;
   STEATOSIS; DASABUVIR
ER

PT J
DE Nanogold; rheumatoid arthritis; inflammation; transcription factor
ID COLLAGEN-INDUCED ARTHRITIS; NANOPARTICLES; CANCER; EXPRESSION;
   INFLAMMATION; ANTIOXIDANTS; CHEMOKINES; SCATTERING; CARTILAGE; CYTOKINES
ER

PT J
ID PROLIFERATOR-ACTIVATED RECEPTORS; INSULIN-RESISTANCE; FATTY-ACID;
   WEIGHT-GAIN; RXR-ALPHA; LIGAND; ROSIGLITAZONE; ANGPTL4; OVEREXPRESSION;
   DYSLIPIDEMIA
ER

EF